J&J to buy Abiomed in $16.6B deal to boost cardiovascular business
November 01, 2022 at 07:31 AM EDT
J&J's cardiovascular devices business will benefit from the $16.6 billion deal to acquire Abiomed. The deal comes at a time when J&J is spinning off its consumer health business.